Plasma high-mobility group box 1 as an indicator of surgical stress

Surgery Today

Volumn 41, Issue 7, 2011, Pages 903-907

  Osoegawa, Atsushi ^a,d   Yano, Tokujiro ^a   Yamanaka, Takeharu ^b   Tagawa, Tetsuzo ^a   Shoji, Fumihiro ^a   Yoshino, Ichiro ^c   Taketomi, Akinobu ^a   Ito, Hiroyuki ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Perioperative period; Plasma high mobility group box 1; Postoperative complications; Surgical stress

Indexed keywords

C REACTIVE PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; AGED; ARTICLE; ATELECTASIS; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; ELECTIVE SURGERY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENERAL SURGERY; HUMAN; LEUKOCYTE COUNT; MALE; OPERATION DURATION; PERIOPERATIVE PERIOD; PLEURA EMPYEMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROTEIN BLOOD LEVEL; SURGICAL STRESS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; STRESS, PSYCHOLOGICAL; SURGICAL PROCEDURES, ELECTIVE;

EID: 79960313208     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4371-4     Document Type: Article

References (22)

1. W.L. Biffl E.E. Moore F.A. Moore V.M. Peterson 1996 Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224 5 647 664 8916880 10.1097/00000658-199611000-00009 1:STN:280: DyaK2s%2FnsVCmsQ%3D%3D (Pubitemid 26384888)
2. H. Sakurai K. Soejima F.C. Schmalstieg M. Nozaki D.L. Traber 2009 Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep Surg Today 39 5 399 406 19408077 10.1007/s00595-008-3879-3 1:CAS:528:DC%2BD1MXlt1Kjurs%3D
3. M.E. Bianchi M. Beltrame G. Paonessa 1989 Specific recognition of cruciform DNA by nuclear protein HMG1 Science 243 4894Pt1 1056 1059 2922595 10.1126/science.2922595 1:CAS:528:DyaL1MXit1Ontrc%3D (Pubitemid 19072581)
4. H. Wang O. Bloom M. Zhang J.M. Vishnubhakat M. Ombrellino J. Che, et al. 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 5425 248 251 10398600 10.1126/science.285.5425.248 1:CAS:528:DyaK1MXks1Sjtb0%3D (Pubitemid 29329996)
5. P. Scaffidi T. Misteli M.E. Bianchi 2002 Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 6894 191 195 12110890 10.1038/nature00858 1:CAS:528:DC%2BD38XltFGlsro%3D (Pubitemid 34773774)
6. R. Palumbo M. Sampaolesi F. De Marchis R. Tonlorenzi S. Colombetti A. Mondino, et al. 2004 Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation J Cell Biol 164 3 441 449 14744997 10.1083/jcb.200304135 1:CAS:528:DC%2BD2cXhtVahsrg%3D (Pubitemid 38174771)
7. A. Tsung R. Sahai H. Tanaka A. Nakao M.P. Fink M.T. Lotze, et al. 2005 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 7 1135 1143 15795240 10.1084/jem.20042614 1:CAS:528:DC%2BD2MXjtFWls7s%3D (Pubitemid 40524681)
8. D.C. Angus L. Yang L. Kong J.A. Kellum R.L. Delude K.J. Tracey, et al. 2007 Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis Crit Care Med 35 4 1061 1067 17334246 10.1097/01.CCM.0000259534.68873.2A (Pubitemid 46598956)
9. T. Jungas P. Verbeke T. Darville D.M. Ojcius 2004 Cell death, BAX activation, and HMGB1 release during infection with Chlamydia Microbes Infect 6 13 1145 1155 15488733 10.1016/j.micinf.2004.07.004 1:CAS:528: DC%2BD2cXos1ChtLw%3D (Pubitemid 39377713)
10. U. Andersson H. Erlandsson-Harris 2004 HMGB1 is a potent trigger of arthritis J Intern Med 255 3 344 350 14871458 10.1111/j.1365-2796.2003.01303.x 1:CAS:528:DC%2BD2cXislKmtbg%3D (Pubitemid 38315275)
11. L.L. Mantell W.R. Parrish L. Ulloa 2006 Hmgb-1 as a therapeutic target for infectious and inflammatory disorders Shock 25 1 4 11 16369179 10.1097/01.shk.0000188710.04777.9e 1:CAS:528:DC%2BD28XosVOntA%3D%3D
12. C. Fiuza M. Bustin S. Talwar M. Tropea E. Gerstenberger J.H. Shelhamer, et al. 2003 Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 7 2652 2660 12456506 10.1182/blood-2002-05-1300 1:CAS:528:DC%2BD3sXivVWgu7k%3D (Pubitemid 36857626)
13. P.L. Sappington R. Yang H. Yang K.J. Tracey R.L. Delude M.P. Fink 2002 HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice Gastroenterology 123 3 790 802 12198705 10.1053/gast.2002.35391 1:CAS:528:DC%2BD38XnsVWhu7s%3D (Pubitemid 34977085)
14. K. Suda Y. Kitagawa S. Ozawa Y. Saikawa M. Ueda E. Abraham, et al. 2006 Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery? Dis Esophagus 19 1 5 9 16364036 10.1111/j.1442-2050.2006.00529.x 1:STN:280:DC%2BD2Mnns1ykuw%3D%3D
15. K. Suda Y. Kitagawa S. Ozawa T. Miyasho M. Okamoto Y. Saikawa, et al. 2007 Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy Dis Esophagus 20 6 478 486 17958722 10.1111/j.1442-2050. 2007.00699.x 1:STN:280:DC%2BD2snjsV2hsQ%3D%3D (Pubitemid 47617831)
16. K. Kawabata M. Suzuki M. Sugitani K. Imaki M. Toda T. Miyamoto 1991 ONO-5046, a novel inhibitor of human neutrophil elastase Biochem Biophys Res Commun 177 2 814 820 2049103 10.1016/0006-291X(91)91862-7 1:CAS:528: DyaK3MXksVWqt7g%3D
17. S. Tamakuma M. Ogawa N. Aikawa T. Kubota H. Hirasawa A. Ishizaka, et al. 2004 Relationship between neutrophil elastase and acute lung injury in humans Pulm Pharmacol Ther 17 5 271 279 15477122 10.1016/j.pupt.2004.05.003 1:CAS:528:DC%2BD2cXotlSlurc%3D (Pubitemid 39345408)
18. A.M. Flohr P. Rogalla M. Meiboom L. Borrmann M. Krohn B. Thode-Halle, et al. 2001 Variation of HMGB1 expression in breast cancer Anticancer Res 21 6A 3881 3885 11911263 1:CAS:528:DC%2BD38Xis1artrw%3D (Pubitemid 34229257)
19. Y.R. Choi H. Kim H.J. Kang N.G. Kim J.J. Kim K.S. Park, et al. 2003 Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation Cancer Res 63 9 2188 2193 12727838 1:CAS:528: DC%2BD3sXjtlGmtrc%3D (Pubitemid 36538625)
20. H. Kuniyasu Y. Chihara H. Kondo 2003 Differential effects between amphoterin and advanced glycation end products on colon cancer cells Int J Cancer 104 6 722 727 12640679 10.1002/ijc.11016 1:CAS:528:DC%2BD3sXjtVWqtr4%3D (Pubitemid 36418509)
21. B. Meyer H. Murua Escobar S. Hauke A. Richter S. Winkler P. Rogalla, et al. 2004 Expression pattern of the HMGB1 gene in sarcomas of the dog Anticancer Res 24 2B 707 710 15161015 1:CAS:528:DC%2BD2cXkvVens7Y%3D (Pubitemid 38625010)
22. A. Taguchi D.C. Blood G. del Toro A. Canet D.C. Lee W. Qu, et al. 2000 Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 6784 354 360 10830965 10.1038/35012626 1:CAS:528:DC%2BD3cXjs1Krurk%3D (Pubitemid 30337069)